{
    "medicine_id": "45f6fc5379052783d55618376f6fbf97b0d59794",
    "platform_id": "DB06358",
    "metadata": {
        "name": "Tepezza 500 mg 1 Injection powder lyophilized for solution",
        "composition": "500 mg 1 Iclaprim",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in bacterial infection skin infections disorders obesity liver disease kidney disease and pneumonia",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00116",
                        "description": "The therapeutic efficacy of Iclaprim can be decreased when used in combination with Tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "The therapeutic efficacy of Iclaprim can be decreased when used in combination with Folic acid"
                    },
                    {
                        "drugbank-id": "DB00650",
                        "description": "The therapeutic efficacy of Iclaprim can be decreased when used in combination with Leucovorin"
                    },
                    {
                        "drugbank-id": "DB02031",
                        "description": "The therapeutic efficacy of Iclaprim can be decreased when used in combination with 6S 5 6 7 8 tetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB02067",
                        "description": "The therapeutic efficacy of Iclaprim can be decreased when used in combination with Triglu 5 formyl tetrahydrofolate"
                    },
                    {
                        "drugbank-id": "DB11596",
                        "description": "The therapeutic efficacy of Iclaprim can be decreased when used in combination with Levoleucovorin"
                    },
                    {
                        "drugbank-id": "DB04789",
                        "description": "The therapeutic efficacy of Iclaprim can be decreased when used in combination with 5 methyltetrahydrofolic acid"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The therapeutic efficacy of Iclaprim can be increased when used in combination with Acetazolamide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}